Casandra
Casandra Test Code GE77232Version 1 (DRAFT)
Performing Lab
Spinocerebellar Ataxia Type 6 Repeat Analysis
Clinical Use
Order TestUse
Diagnostic testing for individuals with clinical features or family history suggestive of spinocerebellar ataxia type 6, which is caused by CAG trinucleotide repeat expansions in the CACNA1A gene.
Special Instructions
Orderable as a single‑gene repeat expansion analysis. Found on GeneDx neurology requisition form under test code TH87, alongside other single‑gene and panel options for spinocerebellar ataxia repeat expansions.
Limitations
Detects only CAG repeat expansion size in CACNA1A; does not detect sequence variants or other mechanisms; repeat sizing may have limitations in range depending on assay.
Test Details
Methodology
PCR-based (PCR)
Biomarkers
CACNA1A
GeneCAG repeat size • Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
Result Turnaround Time
14-28 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided
Related Tests
Other tests from different labs that may be relevant
SCA6 (CACNA1A) Genetic Testing (Repeat Expansion)
Labcorp
Spinocerebellar Ataxia Type 1, 2, 3, 6, or 7, Repeat Expansion Analysis, Varies
Mayo Clinic Lab
Spinocerebellar Ataxia Repeat Expansion Panel, Varies
Mayo Clinic Lab
Comprehensive Spinocerebellar Ataxia Repeat Expansion Panel
Labcorp
SCA1 (ATXN1) Genetic Testing (Repeat Expansion)
Labcorp
Spinocerebellar Ataxia Type 2 via the ATXN2 CAG Repeat Expansion
Prevention Genetics
SCA2 (ATXN2) Genetic Testing (Repeat Expansion)
Labcorp
SCA3 (ATXN3) Genetic Testing (Repeat Expansion)
Labcorp
Machado-Joseph Disease (MJD)/Spinocerebellar Ataxia Type 3 (SCA3) via the ATXN3 CAG Repeat Expansion
Prevention Genetics
SCA36 (NOP56) Genetic Testing (Repeat Expansion)
Labcorp